Regulation of the release of tumour necrosis factor (TNF)α and soluble TNF receptor by γ irradiation and interferon γ in Ewing's sarcoma/peripheral primitive neuroectodermal tumour cells

Journal of Cancer Research and Clinical Oncology

Volumn 123, Issue 5, 1997, Pages 245-252

  Van Valen, F ^a   Kentrup Lardong, V ^a   Truckenbrod, B ^a   Rube C ^a   Winkelmann, W ^a   Jurgens H ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

irradiation; Ewing's sarcoma; Interferon ; Peripheral primitive neuroectodermal tumor; Tumour necrosis factor

Indexed keywords

ACETYLCYSTEINE; GAMMA INTERFERON; MEPACRINE; NORDIHYDROGUAIARETIC ACID; RECOMBINANT GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CONTROLLED STUDY; EWING SARCOMA; GAMMA RADIATION; HUMAN; HUMAN CELL; NEUROECTODERM TUMOR; PRIORITY JOURNAL; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; BONE NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; GAMMA RAYS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERFERON TYPE II; NEUROECTODERMAL TUMORS; PERIPHERAL NERVOUS SYSTEM NEOPLASMS; RADIOTHERAPY, ADJUVANT; RECEPTORS, TUMOR NECROSIS FACTOR; SARCOMA, EWING'S; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031006245     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050055     Document Type: Article

References (42)

1. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wellach D (1992) Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 175:323-329
2. Ambros IM, Ambros PF, Strehl S, Kovar H, Gadner H, Salzer-Kuntschik M (1991) MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration Cancer 67:1886-1893
3. Aruoma OI, Halliwell B, Hoey BM, Butler J (1989) The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical. Superoxide, and hypochlorous acid. Free Radical Biol Med 6:593-597
4. Bertolini DR, Nedwin G, Bringman T, Smith D, Mundy GR (1986) Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factor. Nature 319:516-518
5. Brockhaus M, Schoenfeld HJ, Schläger EJ, Hunziker W, Lesslauer W, Loetscher H (1990) Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA 87:2127-2131
6. Chiang CS, McBride WH (1991) Radiation enhances tumor necrosis factor alpha production by murine brain cells. Brain Res 566:265-269
7. Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T, Naito K, Toshioka T, Hidaka H (1990) Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cycle AMP-dependent photein kinase, N-[(2-(p-bromocinnamylamino)ethyl]-5-isoquinoline sulfonamide (H89), of PC12D pheochromocytoma cells. J Biol Chem 265:5267-5272
8. Dunst J, Sauer R, Burger JMV, Hawliczek R, Kürten R, Winkelmann W, Salzer-Kuntschik M, Müschenich M, Jürgens H (1991) Radiation therapy as local treatment in Ewing's sarcoma. Results of the Cooperative Ewing's Sarcoma studies CESS 81 and CESS 86. Cancer 67:2818-2825
9. Frater-Schröder M, Risau W, Hallmann R, Gaulschi P, Böhlen P (1987) Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc Natl Acad Sci USA 84:5277-5281
10. Garrelds JM, Zijlstra FJ, Tak CJAM. Bonta IL, Beckman I, Ben-Efraim S (1993) A comparison between two methods for measuring tumor necrosis factor in biological fluids. Agent Actions 38:C89-C91
11. Gillard J, Ford-Hutchinson AW, Chan C, Charleson S, Dennis D, Foster A, Fortin R, Leger S, Mc Farlane CS, Morton H, Piechuta H, Riendeau D, Rouzer CA, Rokach J, Young R (1989) L-663-536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butylthio-5-isopropylindol-2-yl)]-2,2-dimethyl propanoic acid), a novel, orally active leukotriene biosynthesis inhibitor. Cand J Physiol Pharmacol 67:456-461
12. Hafner M, Orosz P, Krüger A, Männel DN (1996) TNF promotes metastasis by impairing natural killer cell activity. Int J Cancer 66:388-392
13. Hallahan DE, Spriggs DR, Beckett M. Kule DW, Weichselbaum RR (1989) Increased tumor necrosis factor α mRNA after cellular exposure to ionizing radiation. Proc Natl Acad SCI USA 86:10104-10107
14. Hallahan D, Beckett MA, Kufe DW, Weichselbaum RR (1990) The interaction between recombinant human tumor necrosis factor and reaction in 13 human tumor cell lines. Int J Radiat Oncol Biol Phys 19:69-74
15. Hallahan D, Virudachalam S, Sherman ML, Huberman E, Kufe DW, Weichselbaum RR (1991) Tumor necrosis factor gene expression is mediated by protein kinase C following activation by ionizing radiation. Cancer Res 51:4565-4569
16. Hallahan D, Virudachalam S, Kuchibhotla J, Kufe DW, Weichselbaum RR (1994) Membrane-derived second messenger regulates x-ray-mediated tumor necrosis factor α nene induction. Proc Natl Acad Sci USA 91:4897-4901
17. Hayes MP, Freeman SL, Donnelly RP (1995) IFN-γ priming of monocytes enhances LPS-induced TNF production by augmenting both transcription and mRNA stability. Cytokine 7:427-435
18. Kobayashi E, Nakano H, Morimoto M, Tamaoki T (1989) Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 159:548-553
19. Krivenko S, Dryk M, Komarovskaya M, Karkanitsa (1992) Ionizing radiation increases TNF/cachectin production by human peripheral blood mononuclear cells in vitro. Int J Hematol 55:127-130
20. Krönke M, Hensel G, Schlüter C, Scheurich P, Schütze S, Pfizenmaier K (1988) Tumor necrosis factor and lymphotoxin gene expression in human tumor cell lines. Cancer Res 48:5417-5421
21. McKeon C, Thiele CT, Ross RA, Kwan M, Triche TJ, Miser JS, Israel MA (1988) Indistinguishable patterns of protooncogene expression in two distinct but closely related tumors: Ewing's sarcoma and neuroepithelioma. Cancer Res 48:4307-4311
22. Meltzer MS (1981) Macrophage activation for tumor cytotoxicity: characterization of priming and trigger signals during lymphokine activation. J Immunol 127:179-183
23. Obinata A, Akimoto Y, Hirano H, Endo H (1991) Stimulation by Bt2cAMP of epidermal mucous metaplasia in retinol-pretreated chick embryonic cultured skin, and its inhibition by herbimycin A, an inhibitor for protein-tyrosine kinase. Exp Cell Res 193:36-44
24. Olsson I, Lantz M, Nilsson E, Peetre C, Thysell H, Grubb A (1989) Isolation and characterization of a tumor necrosis factor binding protein from, urine. Eur J Haematol 42:270-275
25. Ostensen ME, Thiele DL, Lipsky PE (1987) Tumor necrosis factor-̈ enhances cytolytic activity of human natural killer cells. J Immunol 138:4185-4191
26. Paller MS, Jacobs HS (1994) Cytochrome P-450 mediates tissue-damaging hydroxyl radical formation during reoxygenation of the kidney. Proc Natl Acad Sci USA 91:7002-7006
27. Pfizenmaier K, Scheurich P, Schlüter C, Krönke M (1987) Tumor necrosis factor enhances HLA-A, B, C and HLA-DR gene expression in human tumor cells. J Immunol 138:975-980
28. Philip R, Epstein LB (1986) Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1. Nature 323:86-90
29. Riley PA (1994) Free radicals in biology: oxidative stress and the effects of ionizing radiation. Int J Radiat Biol 65:27-33
30. Seckinger P, Vey E, Turcati G, Wingfield P, Dayer JM (1990) Tumor necrosis factor inhibitor: purification, NH2-terminal amino acid sequence and evidence for anti-inflammatory and immunomodulatory activities. Eur J Immunol 20:1167-1174
31. Shen CY, Wang D, Chang ML, Hsu K (1995) Protective effect of mepacrine on hypoxia-reoxygenation-induced acute lung injury in rats. J Appl Physiol 78:225-231
32. Spriggs DR, Imamura K, Rodriguez C, Sariban E, Kufe DW (1988) Tumor necrosis factor expression in human epithelial tumor cell lines. J Clin Invest 81:455-460
33. 2 activation and autoinduction of tumor necrosis factor gene expression by tumor necrosis factor. Cancer Res 50:7101-7107
34. Street IP, Lin HK, Laliberte F, Ghomashchi F, Wang Z, Perrier H, Tremblay NM, Huang Z, Weech PK, Gelb MH (1993) Slow-and tight-binding inhibitors of the 85-kDa human phospholipase A2. Biochemistry 32:5935-5940
35. Tsokos M (1992) Peripheral primitive neuroectodermal tumors. Diagnosis, classification, and prognosis. In. Garvin AJ, O'Leary TJ, Bernstein J, Rosenberg HS (eds) Perspectives in pediatric pathology, vol 16. Karger, Basel, pp 27-98
36. Valen F van, Hanenberg H, Jürgens H (1994) Expression of functional very late antigen-α1, -α2, -α3 and -α6 integrins on Ewing's sarcoma and primitive peripheral neuroectodermal tumour cells and modulation by interferon-γ and tumour necrosis factor-α. Eur J Cancer 30A:2119-2125
37. Valen F van, Prior R, Wechsler W, Jürgens H, Keck E (1988) An immunocytochemical and biochemical study of Ewing's sarcoma cells in culture: evidence for neural differentiation in vitro. In: Heuck FHW, Keck E (eds) Osteologia, vol 3. Springer Heidelberg Berlin New York pp 341-348
38. Valen F van, Hanenberg H, Fried C, Bott U, Burdach S, Winkelmann W, Jürgens H, Göbel U (1991) Interferon-γ and tumor necrosis factor-α induce adhesion molecule ICAM-1 and HLA class I antigen expression in Ewing sarcoma cells. Med Pediatr Oncol 19:342
39. Valen F van, Winkelmann W, Burdach S, Göbel U, Jürgens H (1993) Interferon γ and tumour necrosis factor α induce a synergistic antiproliferative response in human Ewing's sarcoma cells in vitro. J Cancer Res Clin Oncol 119:615-621
40. Vanhaesebroeck B, Mareel M, Van Roy F, Grooten J, Fiers W (1991) Expression of the tumor necrosis factor gene in tumor cells correlates with reduced tumorigenicity and reduced invasiveness in vivo. Cancer Res 51:2229-2238
41. Whang-Peng J, Triche TJ, Knutsen T, Miser J, Kao-Shan S, Tsai S, Israel MA (1986) Cytogenetic characterization of selected small round cell tumors of childhood. Cancer Genet Cytogenet 21:185-208
42. Wu XM, Sawada M, Carlson JC (1992) Stimulation of phospholipase A2 by xanthine oxidase in the rat corpus luteum. Biol Reprod 47:1053-1058